The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia
Background: Next-generation sequencing (NGS) offers a method for measurable residual disease (MRD) assessment by detecting leukemia-associated genetic mutations. Objective: This study aimed to evaluate the clinical implications and prognostic value of NGS-based MRD assessment in acute myeloid leukem...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Hematology |
| Online Access: | https://doi.org/10.1177/20406207251349261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|